New COVID vaccine candidate enters human testing
NCT ID NCT04639466
Summary
This study tested a new COVID-19 vaccine called GEO-CM04S1 to see if it is safe and can trigger a protective immune response. It involved 119 healthy adult volunteers. The research aimed to find the best dose and see how well the vaccine works when given as a first course or as a booster shot for people previously vaccinated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
EmVenio Research
Claremont, California, 91711, United States
-
Millennium Clinical Trials
Thousand Oaks, California, 91360, United States
Conditions
Explore the condition pages connected to this study.